FT
FULC icon

Fiduciary Trust’s Fulcrum Therapeutics FULC Stock Holding History

Fiduciary Trust’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Hold
136,555
– – 0.01% 606
2026
Q1 		$1.05M Hold
136,555
– – 0.01% 411
2025
Q4 		$1.54M Hold
136,555
– – 0.02% 332
2025
Q3 		$1.26M Hold
136,555
– – 0.01% 370
2025
Q2 		$939K Hold
136,555
– – 0.01% 413
2025
Q1 		$393K Hold
136,555
– – 0.01% 583
2024
Q4 		$642K Hold
136,555
– – 0.01% 444
2024
Q3 		$488K Hold
136,555
– – 0.01% 474
2024
Q2 		$847K Hold
136,555
– – 0.01% 366
2024
Q1 		$1.29M Hold
136,555
– – 0.02% 304
2023
Q4 		$922K Hold
136,555
– – 0.02% 350
2023
Q3 		$606K Hold
136,555
– – 0.01% 399
2023
Q2 		$451K Hold
136,555
– – 0.01% 464
2023
Q1 		$389K Hold
136,555
– – 0.01% 491
2022
Q4 		$994K Buy
136,555
+4,083
+3% +$26.6K 0.02% 339
2022
Q3 		$1.07M Hold
132,472
– – 0.02% 309
2022
Q2 		$649K Hold
132,472
– – 0.01% 398
2022
Q1 		$3.13M Hold
132,472
– – 0.06% 200
2021
Q4 		$2.34M Buy
132,472
+3,257
+3% +$64.5K 0.04% 232
2021
Q3 		$3.65M Buy
129,215
+3,216
+3% +$60.9K 0.06% 186
2021
Q2 		$1.32M Buy
125,999
+1,000
+0.8% +$10.1K 0.03% 294
2021
Q1 		$1.47M Hold
124,999
– – 0.03% 273
2020
Q4 		$1.46M Hold
124,999
– – 0.03% 274
2020
Q3 		$991K Hold
124,999
– – 0.02% 294
2020
Q2 		$2.29M Hold
124,999
– – 0.06% 201
2020
Q1 		$1.49M Buy
124,999
+104,999
+525% +$1.68M 0.04% 221
2019
Q4 		$333K Buy
20,000
+10,000
+100% +$95.6K 0.01% 433
2019
Q3 		$66K Buy
+10,000
New +$111K ﹤0.01% 508

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fiduciary Trust's FULC Position: Q2 2026 in Review

Fiduciary Trust held its Fulcrum Therapeutics (FULC) position steady in Q2 2026 at 136,555 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #606.

Fiduciary Trust first reported a position in FULC in Q3 2019 and has held it in 28 quarters since. The position peaked at $3.65M in Q3 2021. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Fiduciary Trust held 136,555 shares of Fulcrum Therapeutics worth $500K as of Q2 2026.
  • Fiduciary Trust left its Fulcrum Therapeutics share count unchanged in Q2 2026.
  • Fulcrum Therapeutics made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #606 holding.
  • Fiduciary Trust first reported a position in Fulcrum Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • Fiduciary Trust's Fulcrum Therapeutics position peaked at $3.65M in Q3 2021.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.